Other Long Term Assets - Dizal Jiangsu Pharmaceutical Co Ltd (SSE:688192) - Alpha Spread
D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 33.4 CNY -7.2%
Market Cap: 13.6B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note
Dizal Jiangsu Pharmaceutical Co Ltd
/
Balance Sheet
/
Other Long-Term Assets

Dizal Jiangsu Pharmaceutical Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dizal Jiangsu Pharmaceutical Co Ltd
Other Long-Term Assets Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Other Long-Term Assets
¥17m
CAGR 3-Years
69%
CAGR 5-Years
179%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Long-Term Assets
¥304.3m
CAGR 3-Years
-29%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Other Long-Term Assets
¥283.1m
CAGR 3-Years
N/A
CAGR 5-Years
40%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Other Long-Term Assets
¥8.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Long-Term Assets
¥405.6m
CAGR 3-Years
39%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Long-Term Assets
¥1.2B
CAGR 3-Years
21%
CAGR 5-Years
33%
CAGR 10-Years
46%

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
17m CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Other Long-Term Assets amounts to 17m CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
179%

Over the last year, the Other Long-Term Assets growth was 113%. The average annual Other Long-Term Assets growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been 69% over the past three years , 179% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 179,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.